1868-6958

Cancer Nanotechnology

Springer-Verlag

View prefix report (10.1186)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 308 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact308 DOIs
2

Add abstracts to 142 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Medium impact142 DOIs
3

Deposit reference lists for 20 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact20 DOIs

DOIs for this ISSN

Showing the top 5 of 395 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Gold nanoparticles for cancer radiotherapy: a review (10.1186/s12645-016-0021-x)
Abstract ORCID
130.10 399
2 Antiangiogenic and antiapoptotic effects of green-synthesize… (10.1186/s12645-018-0037-5)
Abstract ORCID
117.90 227
3 Biological mechanisms of gold nanoparticle radiosensitizatio… (10.1186/s12645-017-0026-0)
Abstract ORCID
116.82 216
4 Application of nanotechnology to cancer radiotherapy (10.1186/s12645-016-0024-7)
Abstract ORCID
106.19 132
5 The application of titanium dioxide, zinc oxide, fullerene,… (10.1186/s12645-017-0032-2)
Abstract ORCID
102.27 110
6 AGuIX nanoparticles as a promising platform for image-guided… (10.1186/s12645-015-0012-3)
Abstract ORCID
94.04 75
7 Cancer characterization and diagnosis with SERS-encoded part… (10.1186/s12645-017-0031-3)
Abstract ORCID
89.97 62
8 Electrochemical and optical biosensors for early-stage cance… (10.1186/s12645-017-0035-z)
Abstract ORCID
87.02 54
9 Contact-mediated intracellular delivery of hydrophobic drugs… (10.1186/s12645-014-0008-4)
Abstract ORCID
85.80 51
10 Synthetic nanoparticles for delivery of radioisotopes and ra… (10.1186/s12645-016-0022-9)
Abstract ORCID
84.95 49
11 Cancer resistance to treatment and antiresistance tools offe… (10.1186/s12645-017-0030-4)
Abstract ORCID
84.51 48
12 Platinum nanoparticles: an exquisite tool to overcome radior… (10.1186/s12645-017-0028-y)
Abstract ORCID
83.14 45
13 Enhanced nanoparticle delivery exploiting tumour-responsive… (10.1186/s12645-018-0044-6)
Abstract ORCID
79.55 38
14 Nanotechnology and cancer: improving real-time monitoring an… (10.1186/s12645-016-0015-8)
Abstract ORCID
76.57 33
15 Bio-conjugation of antioxidant peptide on surface-modified g… (10.1186/s12645-016-0013-x)
Abstract ORCID
75.26 31
16 A local effect model-based interpolation framework for exper… (10.1186/s12645-016-0025-6)
Abstract ORCID
70.75 25
17 The study of toxicity and pathogenicity risk of Potato Virus… (10.1186/s12645-018-0036-6)
Abstract ORCID
66.11 20
18 Current state-of-the-art in multi-scale modeling in nano-can… (10.1186/s12645-025-00326-1)
Abstract ORCID
66.11 20
19 Application and perspectives of nanomaterials in boron neutr… (10.1186/s12645-025-00324-3)
Abstract ORCID
63.94 18
20 Engineered exosomes: advanced nanocarriers for targeted ther… (10.1186/s12645-025-00334-1)
Abstract ORCID
62.76 17
21 Optical fibre sensors: their role in in vivo dosimetry for p… (10.1186/s12645-016-0020-y)
Abstract ORCID
61.52 16
22 Nanodrug-based modulation of platelet–leukocyte interactions… (10.1186/s12645-025-00340-3)
Abstract ORCID
61.52 16
23 Evaluation of the performance of Fe3O4/MnO2@doxorubicin hybr… (10.1186/s12645-024-00293-z)
Abstract ORCID
60.21 15
24 Regulation of oxidative stress and inflammation caused by dr… (10.1186/s12645-025-00342-1)
Abstract ORCID
60.21 15
25 An overview of current practice in external beam radiation o… (10.1186/s12645-017-0027-z)
Abstract ORCID
58.80 14
26 Synergistic breast cancer therapy with RGD-decorated liposom… (10.1186/s12645-024-00299-7)
Abstract ORCID
58.80 14
27 PEG-functionalized UiO-66 MOFs for targeted vincristine deli… (10.1186/s12645-025-00315-4)
Abstract ORCID
58.80 14
28 In vitro methodologies to evaluate nanocarriers for cancer t… (10.1186/s12645-025-00321-6)
Abstract ORCID
58.80 14
29 Empowering rapid diagnosis and treatment of glioblastoma wit… (10.1186/s12645-025-00317-2)
Abstract ORCID
57.31 13
30 Potential carriers of chemotherapeutic drugs: matrix based n… (10.1186/s12645-014-0003-9)
Abstract ORCID
55.70 12
31 Intravital microscopy for evaluating tumor perfusion of nano… (10.1186/s12645-016-0016-7)
Abstract ORCID
55.70 12
32 Delivery of melittin-loaded niosomes for breast cancer treat… (10.1186/s12645-021-00085-9)
ORCID
50.94 108
33 Artemisinin-loaded mesoporous silica nanoparticles/electrosp… (10.1186/s12645-024-00296-w)
Abstract ORCID
50.00 9
34 Advantages of gadolinium based ultrasmall nanoparticles vs m… (10.1186/s12645-014-0004-8)
ORCID
49.33 93
35 Mesoporous silica nanotechnology: promising advances in augm… (10.1186/s12645-024-00250-w)
ORCID
49.09 91
36 The role of mitochondrial function in gold nanoparticle medi… (10.1186/s12645-014-0005-7)
ORCID
48.11 83
37 Nanoparticles advanced from preclinical studies to clinical… (10.1186/s12645-023-00174-x)
ORCID
47.71 80
38 Acoustic waves and smart biomimetic nanoparticles: combinati… (10.1186/s12645-024-00281-3)
Abstract ORCID
47.71 8
39 β-cyclodextrin-based multifunctional carriers for colon-targ… (10.1186/s12645-025-00339-w)
Abstract ORCID
47.71 8
40 Nanocarrier-mediated photothermal therapy and its combined s… (10.1186/s12645-025-00349-8)
Abstract ORCID
47.71 8
41 Green-synthesized silver nanoparticles from peel extract of… (10.1186/s12645-024-00285-z)
Abstract
47.44 78
42 Targeting nano-regulator based on metal–organic frameworks f… (10.1186/s12645-023-00200-y)
ORCID
47.30 77
43 Particle therapy and nanomedicine: state of art and research… (10.1186/s12645-017-0029-x)
Abstract
46.43 71
44 Radiolabeled nanomaterial for cancer diagnostics and therape… (10.1186/s12645-023-00165-y)
ORCID
45.97 68
45 Cell localisation of gadolinium-based nanoparticles and rela… (10.1186/s12645-014-0006-6)
ORCID
45.81 67
46 A biocompatible nanoformulation of curcumin analogue and cur… (10.1186/s12645-024-00286-y)
Abstract ORCID
45.15 7
47 Nanomaterials in cancer immunotherapy: targeting cancer-asso… (10.1186/s12645-024-00302-1)
Abstract ORCID
45.15 7
48 Magnetic hyperthermia of breast cancer cells and MRI relaxom… (10.1186/s12645-018-0042-8)
Abstract
44.81 61
49 Could nanoparticle corona characterization help for biologic… (10.1186/s12645-014-0007-5)
ORCID
44.45 59
50 Doxorubicin-loaded liposomes surface engineered with the mat… (10.1186/s12645-023-00169-8)
ORCID
44.27 58